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The induction of the adaptive immune response 
to an infectious agent consists of a defined series 
of events prompted by invasion of the body by 
the organism, followed by replication of the 
organism and the subsequent initiation of an 
innate and adaptive immune response. For or­
ganisms that enter at a body surface and confine 
replication primarily to that site, for example, infec­
tion of the respiratory tract by seasonal type A 
influenza, innate responses are triggered by in­
fection of cells at the body surfaces and activa­
tion of sentinel innate immune cells in the 
surrounding tissues. Induction of the adaptive 
immune response typically requires the uptake/
infection by the organism or uptake of its con­
stituents by tissue­resident professional APCs, 
most notably immature DCs (Banchereau and 
Steinman,  1998;  Lambrecht  et  al.,  2001;  de 
Heer et al., 2005). These professional APCs trans­
port the organism or its products to secondary 
lymphoid organs, usually LNs draining the site 
of infection (draining LN [DLN]) where adap­
tive immune (T and B cells) responses are 
initiated. In the case of experimental mouse in­
fluenza infection, at least two distinct subsets of 
respiratory DCs (RDCs) have been implicated 
as  critical  APCs  in  the  induction  of  primary   
T cell responses to this virus (GeurtsvanKessel   
et al., 2008; Kim and Braciale, 2009).
The outcome of the interaction between an 
invading microorganism and the immune sys­
tem is either clearance of the agent or the devel­
opment of chronic persistent infection. Viruses 
such as HIV, HCV, and, in the mouse model, 
LCMV, can produce chronic persistent infec­
tion with high titers of the virus because of the 
ability of these viruses to subvert or suppress 
the host immune response (Ahmed et al., 1984; 
Bevan and Braciale, 1995; Letvin and Walker, 
2003;  Wherry  et  al.,  2003;  Rehermann  and 
Nascimbeni, 2005). Persistence of viral antigen 
at high levels in these infections may contribute 
to the dysregulation of the adaptive immune 
response observed in these infections (Shin and 
Wherry, 2007). In contrast, acute infection with 
many viruses results in rapid virus clearance (even 
with an initial high level of virus replication) 
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Acute viral infections induce robust adaptive immune responses resulting in virus clearance. 
Recent evidence suggests that there may be depots of viral antigen that persist in draining 
lymph nodes (DLNs) after virus clearance and could, therefore, affect the adaptive immune 
response and memory T cell formation. The nature of these residual antigen depots, the 
mechanism of antigen persistence, and the impact of the persistent antigen on memory  
T cells remain ill defined. Using a mouse model of influenza virus infection of the respiratory 
tract, we identified respiratory dendritic cells (RDCs) as essential for both sampling and 
presenting residual viral antigen. RDCs in the previously infected lung capture residual viral 
antigen deposited in an irradiation-resistant cell type. RDCs then transport the viral anti-
gen to the LNs draining the site of infection, where they present the antigen to T cells. 
Lastly, we document preferential localization of memory T cells to the DLNs after virus 
clearance as a consequence of presentation of residual viral antigen by the migrant RDC.
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Several groups have, however, reported that influenza viral 
antigen can persist in vivo for weeks after virus clearance in 
the form of processed antigen recognized by adoptively trans­
ferred CD8+ (or CD4+) virus­specific TCR Tg T cells (Jelley­
Gibbs et al., 2005, 2007; Zammit et al., 2006). Indeed, after 
sublethal i.n. infection with the type A influenza A/PR/8 vi­
rus, we could also reproducibly detect the presence of viral 
antigen in the draining mediastinal LN (MLN) for at least 30 d, 
as measured by the proliferation of A/PR/8­specific naive 
CD8+ or CD4+ TCR Tg T cells in the draining MLN after 
adoptive transfer of the naive T cells at this time (Fig. 1 B). 
Adoptive transfer of these Tg T cells into mice infected with 
the antigenically distinct type A X­31 influenza strain did not 
result in proliferation (Fig. 1 B), verifying the antigen depen­
dence and specificity of proliferation.
In view of the rapid clearance of infectious virus from the 
lungs in the face of antigen persistence, we performed a com­
panion analysis to determine the presence of viral RNA over 
time in the lungs and MLN of infected mice by RT­PCR. As 
Fig. 1 C demonstrates, the influenza gene encoding the abun­
dant nucleocapsid protein (NP) is readily detectable in both 
the lungs and the MLN for up to 10 d p.i. Noninfectious virus 
introduced by the i.n. route was rapidly eliminated (i.e., input 
virion NP genes were eliminated from lungs by day 5 after 
inoculation.). The NP gene was also detectable in the lungs 
for up to 30 d when a sensitive nested RT­PCR strategy was 
used for detection. Consistent with these findings, we could 
readily detect (as expected) NP­expressing (NP+) cells among 
the lung airway epithelial cells by immunofluorescence at day 
5 p.i. (Fig. 1 D, top). It is of interest that we could also detect 
NP+ cells at day 30 p.i., but the cells were clustered in rare 
foci associated with sites of residual mild inflammation and fi­
brosis (Fig. 1 D, bottom; and Fig. S1). NP+ cells were demon­
strable  both  among  CD45  lung  parenchyma  cells  and 
hematopoietic (CD45+) cells within these inflammatory foci, 
with predominant NP expression among the CD45 nonhe­
matopoietic cell types (Fig. S1). It should be noted that com­
pared with the day 5 p.i. time point, NP expression in these 
cells was very low, thereby requiring high­gain microscopic 
settings to visualize these rare cells and precluding additional 
characterization of the NP+ cells by flow cytometry because 
of their rarity and low signal intensity. The influenza NP­
specific antibody did not stain the lungs of mice infected with 
the antigenically distinct RSV (Fig. S1). The presence of viral 
antigen as late as 30 d p.i. raised the possibility that there was 
viral mRNA present in the previously infected lungs at this 
late time. The presence of influenza viral mRNA was verified 
by the detection of the mRNA encoding the NEP (NS2) 
protein, which is produced by alternative splicing of the NS1 
gene segment (Fig. 1 E). We extended these results to include 
a quantitative analysis of the kinetics of expression of a third 
influenza gene, i.e., the spliced M2 mRNA, in the lungs using 
real­time RT­PCR (Fig. S2).
It is particularly noteworthy that we were unable to de­
tect the presence of influenza viral RNA in the MLN after 
day 10 p.i., even using the sensitive nested RT­PCR (Fig. 1 C), 
and, presumably, elimination of virus­infected cells by the 
action of the adaptive and innate immune response.
Recently, however, evidence has emerged to suggest that 
after acute viral infection viral antigen can be detectable for 
an extended period, i.e., weeks to months, after clearance of 
infectious virus. This phenomenon is not only observed with 
viruses capable of establishing persistent infection in vitro,   
for example, respiratory syncytial virus (RSV; P’ringle et al., 
1978; Schwarze et al., 2004) and Sendai virus (Mori et al., 
1995), but has also been observed for classically lytic viruses, 
such as type A influenza (Jelley­Gibbs et al., 2005; Zammit   
et al., 2006) and VSV (Turner et al., 2007), which are not 
believed to produce chronic persistent infection of cells. In 
these instances, viral antigen was detected using the prolifera­
tive response of adoptively transferred TCR transgenic (Tg) 
T cells into previously infected animals as a sensitive measure 
of antigen persistence. Although the nature and the mecha­
nism of antigen persistence in these instances was not de­
fined, several studies provided evidence that the presentation 
of this residual viral antigen to T cells may influence the qual­
ity of the memory T cell response to infection (Jelley­Gibbs 
et al., 2005, 2007; Zammit et al., 2006; Turner et al., 2007; 
Woodland and Kohlmeier, 2009).
In several studies reporting persistence of viral antigen   
after acute infection and subsequent virus clearance, the reser­
voir of antigen (as detected by adoptive transfer of virus­specific 
T cells) was localized within secondary lymphoid organs, 
most notably the LN draining the site of infection (Jelley­
Gibbs et al., 2005, 2007; Zammit et al., 2006). In this paper, 
we describe a series of experiments to investigate the under­
lying mechanism of the persistence of antigen presentation 
after respiratory tract infection with type A influenza virus. 
We found that a reservoir of viral antigen (i.e., RNA and 
protein) is present for an extended period after an acute influ­
enza virus infection at the site of infection (i.e., the lungs) and 
localized to both nonhematopoietic (CD45) and hemato­
poietic (CD45+) cell types within residual mild lung inflam­
matory foci. We further demonstrate that the residual viral 
antigen deposited in the previously infected lung is captured 
and transported by RDC to the regional LN, where the   
migrant RDC function in presenting the residual antigen to 
T cells. In addition, we provide evidence that lung follicular 
DCs (FDCs) may play an important role in regulating the re­
sponse of RDC. Finally, our results suggest that as a conse­
quence of presentation of residual viral antigen by the migrant 
RDC to T cells in the LNs draining the site of infection, 
there is preferential localization of memory T cells to the 
DLN after virus clearance. The implications of these observa­
tions are discussed.
RESULTS
Viral antigen persistence in the influenza-infected lungs
In the mouse model of influenza infection, type A influenza 
viruses are rapidly cleared from the lungs after intranasal (i.n.) 
infection, with infectious virus typically becoming undetect­
able in the lungs by days 8–10 post infection (p.i.; Fig. 1 A). JEM VOL. 207, June 7, 2010 
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was restricted to the draining MLN, raising the 
possibility  that  this  depot  of  residual  antigen 
within lungs needed to be transported to the 
MLN. We recently reported that two distinct 
subsets  of  RDC,  i.e.,  CD103+  RDC  and 
CD11bhi RDC, play a central role as APC for 
induction of naive influenza virus–specific CD8+ 
T cell responses in the draining MLN after their 
migration from influenza­infected lungs to this site (Sung et al., 
2006; Hao et al., 2008; Kim and Braciale, 2009). We therefore 
wanted to explore the possibility that one or both of these 
RDC subsets may continue to capture the now residual viral 
antigen in lungs and transport it to the draining MLN after virus 
clearance and recovery from infection.
These two CD11c+MHC IIhi RDC subsets are present, 
along with CD11c+MHC IIlo monocyte­like RDC (MoRDC), 
in the uninfected lungs (Fig. 2 A; Sung et al., 2006). Although, 
as previously reported (GeurtsvanKessel et al., 2008; Kim and 
Braciale, 2009), these RDC subsets transiently migrate out of 
the lungs into the draining MLN (see following paragraph) in 
response to influenza infection, these two MHC IIhi RDC 
subsets begin to return to a normal percentage distribution among 
the CD11c+ cells in lungs by day 40 p.i. (Fig. 2 A), with a 
slightly higher absolute numbers of these two RDC subsets at 
this time than in the naive lungs (5.4 ± 0.5 vs. 11 ± 0.6 × 104 
in spite of the presence of viral antigen in the MLN for at 
least 30 d as detected by proliferation of naive TCR Tg   
T cells (Fig. 1 B). Therefore, the viral antigen appears to be 
deposited/retained within the draining MLN long after viral 
transcripts have disappeared from this site. It is noteworthy, 
however, that although viral RNA and protein were detect­
able in the infected lungs out to day 30 p.i., we and others 
(Román et al., 2002; Lawrence and Braciale, 2004) had pre­
viously reported that influenza­specific naive T cells are un­
able to activate and proliferate in the infected lungs even at 
the height of infection, i.e., days 3–5 p.i., when viral antigen 
and virus­infected cells are highly abundant.
Role of RDCs in antigen presentation in the draining MLN.
The findings in the previous section suggested that the previ­
ously infected lungs represented a depot of influenza virus an­
tigen. However, presentation of this persistent viral antigen 
Figure 1.  Viral antigen persistence in the influenza-
infected lungs. (A) Kinetic analyses of infectious virus 
recovery from the influenza (A/PR/8)-infected lungs. 
Bronchoalveolar lavages were collected at the indicated 
days p.i. and assayed for infectious virus titers using 
MDCK cells. The horizontal line indicates the limit of 
detection. Viral titers are represented as mean TCID50 
(median tissue culture infective dose) ± SEM. (B) Dura-
tion of antigen presentation in the regional LN draining 
the lung. Previously, influenza-infected mice received i.v. 
CFSE-labeled HA-specific TCR Tg CD8+ (Cl-4) or CD4+ 
(TS1) T cells at the indicated days p.i. Proliferation in vivo 
was monitored by CFSE dilution 4 d later in the draining 
MLN. Antigen specificity was measured by transferring 
the reporter Tg T cells into mice that were previously 
infected with an antigenically irrelevant type A influenza 
virus (X31). Data are representative of at least five inde-
pendent experiments. (C–E) Viral antigen persistence in 
the infected lung. Total RNA was extracted from MLN or 
lungs at the indicated days p.i. and subjected to RT-PCR 
analyses to detect NP RNA (with two rounds of PCR; C) 
or unspliced and spliced variants of NS gene (one round 
of PCR; E). RNA from RSV-infected lungs or an influenza-
infected mouse lung epithelial cell line (MLE) was in-
cluded as a control for primer specificity. Lung sections 
were stained for viral NP at day 5 (d5; top) or day 30  
(bottom) p.i. and visualized by immunofluorescence  
microscopy (20×, D). Left, light fields; middle, anti-NP 
immunostaining; right, inverted view of the anti-NP  
immunostaining. TA, terminal airway. Data are represen-
tative of at least four independent experiments. Arrows 
indicate NP-positive cells. Bar, 200 µm.1164 Persistent antigen depots and local T cell responses | Kim et al.
RDC, P = 0.0001, n = 4–6 per MLN at day 0 and day 20 p.i., 
respectively). Among the other CD11c+ cells in the enlarged 
MLN are B220+ plasmacytoid DC (pDC) and the CD8+ 
LN­resident DC. We were able to further confirm the respi­
ratory tract origin of the CD103+ and CD11bhi DC in the 
draining MLN by administration of fluorescent­labeled anti­
gen (OVA­DQ) into the respiratory tract of mice at day 20 p.i. 
When the DC populations in the draining MLN were ana­
lyzed for the uptake of antigen 24 h later, antigen uptake was 
largely restricted to the CD103+ and CD11bhi DC subsets in 
the nodes (Fig. 3 B), which was as expected if these cells were 
migrant RDCs, which had sampled antigen deposited in the 
lungs before their migration to the MLN.
In contrast to their RDC counterparts found in lungs at 
day 20 p.i. (Fig. 2 B), the CD103+ and CD11bhi RDC in the 
draining MLN expressed elevated levels of costimulatory li­
gands (Fig. 3 C). When the major LN DC subsets with po­
tential APC capacity, i.e., CD8+ DC, pDC, and the 
migrant CD103+ and CD11bhi RDC, were isolated from 
the draining MLN at day 20 p.i. and analyzed directly ex 
vivo for APC activity, only the two RDC subsets were ca­
pable of stimulating proliferation of naive influenza­specific 
Tg CD8+ T cells after in vitro co­culture (Fig. 3 D). CD8+ 
DC and pDC pulsed with a high concentration of processed 
peptide could, like CD103+ and CD11bhi RDC, support   
naive T cell activation in vitro. These data suggested that these 
two migrant RDC subsets, which have captured residual   
viral antigen in the lungs before their migration to the DLNs, 
account for the residual antigen­presenting activity observed 
in the MLN. The corresponding immature CD103+ and 
CD11bhi RDC isolated from the lungs at day 20 p.i. did 
contain processed viral antigen, as they could stimulate naive 
CD8+ T cells in vitro (Fig. S4). As expected, however, these 
lung­resident immature CD103+ and CD11bhi RDC only 
weakly stimulated proliferation of naive T cells, presumably 
reflecting the weak costimulatory capacity of these imma­
ture lung DC.
Residual antigen presentation to CD8+ T cells in vivo  
in the MLN depends on migrant RDC.
The findings in the previous section raised the possibility that 
residual viral antigen in the lung continues to be captured and 
transported by RDC to the draining MLN after virus clear­
ance and recovery from infection. To further establish the 
role of RDC in residual antigen uptake and presentation in 
vivo, we used Tg mice expressing diphtheria toxin (DTx) re­
ceptor (DTR) under CD11c promoter (CD11c­DTR) to 
deplete CD11c+ DC (Jung et al., 2002) from the influenza­
infected mice after virus clearance and resolution of infection. 
We have previously demonstrated that i.n. administration of 
a low dose of DTx into the CD11c­DTR mice preferentially 
depletes the CD103+ and CD11bhi RDC from the naive lung 
and that DTx treatment consequently eliminates the migration 
to and accumulation of these RDC in the inflamed MLN   
after influenza virus infection (Kim and Braciale, 2009). 
When low­dose DTx was delivered i.n. to the CD11c­DTR 
for CD103+ RDC, P < 0.001, n > 6; and 4.2 ± 0.9 vs.   
10.7 ± 0.6 × 104 for CD11bhi RDC, P = 0.001, n > 6 per 
lung set at day 0 and day 40 p.i., respectively). At day 20 p.i., 
the CD103+ RDC and CD11bhi RDC in the lungs express 
low levels of the costimulatory ligands CD40/80/86 (Fig. 2 B), 
which are comparable to the corresponding tissue­resident 
immature RDC isolated from the uninfected lungs (Fig. S3; 
Kim and Braciale, 2009).
DCs with cell surface markers characteristic of these two 
MHC IIhi RDC subsets are present at low frequency in the 
draining MLN before infection (Fig. 3 A; Kim and Braciale, 
2009). The presence of these RDCs in the LN presumably 
reflects the well recognized low­level homeostatic migration 
of tissue DC into the draining nodes in the absence of an in­
flammatory stimulus (Jakubzick et al., 2008). As previously 
reported (Kim and Braciale, 2009), the frequency of these two   
RDC subsets found in the draining MLN increases significantly 
by day 3 after influenza infection (Fig. 3 A). By day 20 p.i., 
DCs with phenotypic markers characteristic of these two 
RDC subsets are still detectable in the draining MLN (Fig. 3 A). 
These DCs in the enlarged day­20­p.i. LNs are present in ele­
vated numbers compared with the normal (preinfection) LNs 
(0.5 ± 0.1 vs. 5.8 ± 1.2 × 103 for CD103+ RDC, P = 0.0005, 
n = 4–6; and 0.6 ± 0.09 vs. 10.8 ± 1.4 × 103 for CD11bhi 
Figure 2.  Characterization of RDC subsets in the lung after i.n. 
influenza virus infection. (A) CD103+ RDC (I), CD11bhi RDC (II), and 
MoRDC (III) in the uninfected and infected lungs are identified among 
CD45+CD11c + lung cells by flow cytometry at the indicated days p.i. Data 
are representative of analyses from >20 individual mice performed at 
each time point. (B) Surface marker expression on subsets of RDC. Lung-
residing DC subsets (CD103+ RDC, I; CD11bhi RDC, II; and MoRDC, III) were 
examined at day 20 p.i. for surface expression of costimulatory molecules 
as indicated (open histograms). Staining with isotype-matched control 
antibodies was included (filled histograms). Data are representative of 
results from >10 mice analyzed in three independent experiments.JEM VOL. 207, June 7, 2010 
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into the DTx­treated 
CD11c­DTR mice 
at day 3 after DTx 
treatment and ana­
lyzed T cell proliferation in the MLN 4 d later (Fig. 4 C). In 
contrast to the control group, where a substantial fraction of 
transferred CD8+ T cells underwent several rounds of cell divi­
sion, the Tg T cells in the MLN of DTx­treated mice failed to 
proliferate. The inability of the transferred CD8+ T cell to pro­
liferate was not a result of the simultaneous depletion of antigen­
presenting DC both in the LN and in the lungs after DTx 
administration. As reported previously by us (Kim and Braciale, 
2009), Tg CD8+ T cells can proliferate in the MLN when   
infectious influenza virus is delivered to the DTx­treated 
CD11c­DTR mice via the i.v. route, where the virus in the blood­
stream can gain direct access to the LN­resident DC (Fig. 4 D).
mice at day 20 p.i., we observed that CD103+ and CD11bhi 
RDC were preferentially eliminated from the lung at 24 h 
after DTx treatment (Fig. 4 A), as has been observed in the 
uninfected CD11c­DTR lungs (Kim and Braciale, 2009). 
Consistent with the lung origin of CD103+ and CD11bhi 
found  in  the  lung­draining  MLN,  the  accumulation  of 
those  DC  subsets  in  the  MLN  was  markedly  diminished 
when DC populations in the MLN were examined 3 d after 
DTx treatment (Fig. 4 B). These data further support the no­
tion that continual emigration of tissue­derived DC to DLN 
is the major contributor to DC subsets, with these phenotypic 
characteristics found in tissue DLNs before and/or after in­
flammatory stimuli like virus infection.
To monitor the impact of RDC depletion on residual   
viral antigen presentation activity in the MLN, we adoptively 
transferred CFSE dye­labeled naive CL­4 CD8+ T cells 
Figure 3.  Migrant RDC in the regional 
DLN of the previously infected mice sup-
port antigen-specific T cell proliferation. 
(A) Flow cytometry–based categorization of 
RDC subpopulations in the MLN of previously 
infected mice. The CD11c+ cells found in the 
MLN are divided into three major subsets: 
pDC (B220+ MHC IIlo, I), CD8+ LNDC  
(CD8+ MHC IIint, II), and migrant RDC 
(CD8B220MHC IIhi, III). The migrant RDCs 
are further divided into two populations 
based on CD103 marker expression: CD103+ 
(CD103+ RDC) and CD103 (CD11bhi RDC) 
cells. Data are representative of more than 
five mice analyzed in five independent experi-
ments. (B) In vivo uptake by RDC of soluble 
protein delivered to the respiratory tract before 
RDC migration to the DLN. Mice (day 20 p.i.) 
were given i.n. fluorescent dye–labeled OVA 
(OVA-DQ) or unlabeled OVA proteins. Migrant 
DCs that had taken up the soluble OVA pro-
tein in the respiratory tract were identified in 
the MLN 1 d later. Data are representative of 
four mice in two independent experiments.  
(C) Phenotypic features of DC subsets in the 
MLN of influenza-infected mice (day 20 p.i.). 
Levels of costimulatory molecule expression 
on CD8+ LNDC, CD103+ RDC, and CD11bhi 
RDC were determined at either day 3 (gray)  
or day 20 (open) after infection. Black histo-
grams represent isotype-matched control  
Ab stainings. Data are representative of  
two mice in two independent experiments.  
(D) Migrant RDC isolated from MLN can stim-
ulate proliferation of naive Tg CD8+ T cells 
directly ex vivo. The indicated individual DC 
subsets were separated by cell sorting of MLN 
cell suspensions from pooled LN of previously 
infected mice (day 20 p.i., n = 15–20 mice/
experiment) and then co-cultured with CFSE-
labeled HA-specific naive TCR Tg CD8+ T cells 
for 4 d in cultures. Sorted DC preparations 
were incubated with the preprocessed  
synthetic cognate peptide (HA533-541) before 
co-culture with the responding T cells as a 
positive control. Data are representative of 
three independent experiments.1166 Persistent antigen depots and local T cell responses | Kim et al.
proliferation observed in control mice (i.e., X­31 infected; 
Fig. 5 B, right). Moreover, more pronounced proliferative 
expansion was observed in CD4+ than CD8+ T cells (Fig. 5 B). 
The greater expansion of CD4+ than CD8+ T cells was also 
observed in the MLN of the nonchimeric mice previously 
infected with A/PR/8 virus 50 d before (Fig. 5 B, left). 
These data indicate that the depot of viral antigen in the lung 
is surprisingly long lasting and contained within or dependent 
on a cell type that is resistant to irradiation and, most likely, 
of nonhematopoietic origin (CD45).
To further verify that antigen transportation and presen­
tation of residual antigen in the chimeric mice is also depen­
dent on RDC, we depleted the CD103+ and CD11bhi RDC 
from the lungs of the reconstituted mice by i.n. DTx treat­
ment 4 wk after BM reconstitution (Fig. 5 A). As expected, 
the  CD11chiMHC  IIhi  RDC  (i.e.,  CD103+  and  CD11bhi 
RDC) in the reconstituted hosts were preferentially depleted 
from the lung after i.n. DTx administration, with analysis at 
24 h after treatment (Fig. 5 C), and also from the MLN 3 d 
after treatment, which is indicative of the BM origin of and 
DTR expression by the CD11c+ RDC in the chimeric mice. 
To measure the antigen­presenting activity in the MLN of 
the RDC­depleted mice, labeled Tg T cells were adoptively 
transferred into the DTx­treated mice 3 d after treatment. 
The T cell proliferation in the MLN of the RDC­depleted 
chimeric mice was greatly diminished when examined 4 d 
The depot of viral antigen in the lung transported by RDC  
is radio resistant
The findings in the previous section implicated migrant RDC 
as the cell type presenting residual viral antigen to T cells in 
the MLN. The results of immunofluorescence analysis of   
viral antigen deposition in the lungs (Fig. 1 and Fig. S1) indi­
cated that the residual viral antigen is deposited both in CD45+ 
cells of hematopoietic origin, presumably including CD103+ 
and CD11bhi RDC, and in CD45 parenchymal cells present 
in the infected lung. To explore the contribution of radia­
tion­resistant, likely nonhematopoietic, cells, we irradiated 
previously influenza virus–infected mice at day 20 p.i. and 
reconstituted them with BM cells isolated from naive CD11c­
DTR mice (Fig. 5 A). To examine the ability of the newly 
repopulated RDC in the lungs of these previously infected 
mice to present antigen and activate T cells in the MLN, at 
4–5 wk after reconstitution (i.e., 7 wk after primary infection 
with either A/PR/8 virus or as a control the X­31 virus strain) 
these mice, along with nonchimeric wild­type (unirradiated/
nonreconstituted) infected mice, received, by adoptive trans­
fer, CFSE dye­labeled Tg CD4+ or CD8+ Tg T cells as used 
in Fig. 1. We analyzed T cell proliferation in the MLN 4 d 
after transfer. Both hemagglutinin (HA)­specific TCR Tg 
CD4+ and CD8+ T cells had proliferated in the chimeric 
mice that had been previously infected with A/PR/8 influenza 
virus (Fig. 5 B, middle), which is in contrast to the minimal 
Figure 4.  Residual antigen presentation 
to CD8+ T cells in vivo in the MLN de-
pends on migrant RDC. (A and B) Selective 
ablation of CD103+ and CD11bhi RDC from the 
previously infected lungs resulted in near 
absence of the corresponding populations in 
the lung-draining MLN. CD11c-DTR mice re-
covering from influenza virus (day 20 p.i.) 
were given DTx i.n., and depletion of RDC in 
the lung was analyzed 24 h later (percentage 
of DC among CD11c+SiglecF cells: 15.2 ± 3.7 
vs. 1.5 ± 0.7 for CD103+, P < 0.012, and 47.5 ± 
6.4 vs. 17.6 ± 5.3 for CD11bhi RDC, P < 0.006, 
for PBS-treated vs. DTx-treated mouse panels, 
respectively; mean ± SEM; A) or in the DLN at 
72 h (percentage of DC among total LN cells: 
0.09 ± 0.01 vs. 0.03 ± 0.006 for CD103+, P < 
0.003, and 0.12 ± 0.02 vs. 0.04 ± 0.001 for 
CD11bhi RDC, P < 0.008, for PBS-treated vs.  
DTx-treated mouse panels, respectively; mean ±  
SEM; B) after DTx treatments. Data in A and B 
is representative of at least three independent 
experiments with two animals per experi-
ments. (C and D) The ability of T cells to pro-
liferate in vivo in the lung-draining MLN was 
abrogated with the depletion of migrant RDC. 
PR/8-infected CD11c-DTR mice (day 20 p.i.) 
were treated with DTx (or PBS). CFSE-labeled 
HA-specific CL-4 CD8+ Tg T cells were then transferred i.v. into the previously infected treated mice 3 d later. The ability of the reporter T cells to prolifer-
ate in the MLN was examined 4 d after the adoptive transfer and depicted as the percentage of divided cells (mean ± SEM; P = 0.0003; C). Transferred  
T cells in the DLN of migrant RDC-depleted mice proliferate in response to i.v. influenza virus administration (D). Data in C and D are representative of  
two to four individual recipient mice analyzed in two separate experiments.JEM VOL. 207, June 7, 2010 
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signaling to FDC (Mackay et al., 1997; Huber et al., 2005; 
GeurtsvanKessel et al., 2009) by administration of soluble 
lymphotoxin­ receptor (LTR)–Ig to the previously infected 
mice before adoptive transfer of TCR Tg T cells as described 
(Fig. S5 B). Consistent with a diminution of FDC found in 
the lung (>50%) at the late days of infection (unpublished data), 
LTR­Ig–mediated depletion of FDC (Fig. S5 A) markedly in­
hibited the ability of RDC to support T cell proliferation in the 
draining MLN (Fig. S5, C and D). This was not simply the result 
of an impairment of T cell homing into the immune­reactive 
LN, possibly caused by the destruction of lymphoid architecture 
and/or reduction of chemokine (i.e., CCL21), because this regi­
men at an earlier day after infection (i.e., day 15)—when an­
tigen depots in the lungs are not restricted to a small subsets of 
lung cells—has no or minimal impact on recruitment (and sub­
sequent proliferation) of the reporter T cells in the DLN (Fig. 
S6). These findings raise the possibility that a major reservoir of 
residual viral antigen may lie within iBALT structures.
Persistent antigen presentation by migrant RDC contributes 
to the elevated memory T cell pool in the draining MLN
The demonstration of a residual depot of viral antigen after 
virus infection has led to speculation that such antigen depots 
later (Fig. 5 D). This diminished T cell proliferation seen in 
the DTx­treated chimeric mice was not a result of depletion 
of DC with antigen­presenting capacity in the MLN. The Tg 
T cells in the MLN were fully capable of activation and pro­
liferation when influenza virus was delivered directly to the 
LNs by the i.v. route (Fig. 5 E). These findings suggest that 
there may be a reservoir of viral antigen present in a popula­
tion of radiation­resistant, possibly CD45, cells in the previ­
ously infected lungs and that RDC, particularly CD103+ and 
CD11bhi, are the crucial cell types for sampling residual viral 
antigen deposited in the radio­resistant lung cells.
Infection with influenza virus represents a strong inflamma­
tory stimulus to the mouse lungs and results in the development 
of inducible bronchial­associated lymphoid tissue (iBALT; 
Moyron­Quiroz et al., 2004). A feature of iBALT is the forma­
tion and/or accumulation of CD45 FDC (as well as CD45+ B 
lymphocytes) within these inflammatory cell foci (Fig. S5 A; 
GeurtsvanKessel et al., 2009; Halle et al., 2009). Given the well 
recognized role of the FDC as an antigen depot (Mandels et al., 
1980), we examined the impact of elimination of FDC from the 
lungs of previously infected mice on the ability of RDC to cap­
ture antigen in the lungs and stimulate the proliferation of T cells 
in the DLN. To eliminate FDC, we blocked lymphotoxin­ 
Figure 5.  The depot of viral antigen in the lung 
transported by RDC is radio resistant. (A) Sche-
matic depiction of irradiation and BM transplantation. 
Wild-type mice recovering from acute influenza virus 
infection (3 wk after infection) underwent total 
body irradiation with a lethal dose and then were 
reconstituted with BM cells prepared from naive (un-
infected) CD11c-DTR Tg mice. Mice were analyzed >4 wk 
after BM transplantation. (B) Antigen presentation  
persists in the DLN of the irradiated and BM reconsti-
tuted mice. Irradiated/reconstituted and control unir-
radiated mice received either CFSE-labeled Cl-4 (CD8+) 
or TS1 (CD4+) T cells by i.v. at day 50 p.i. T cell prolif-
eration (CFSE dilution) in the DLN was measured 4 d 
later. X31-infected mice were included as a control for 
antigen specificity of the T cell response. (C) Engraft-
ment of CD11c-DTR–derived RDC in the previously 
infected non-Tg mice. Reconstituted mice were 
treated i.n. with DTx (or PBS) route at >4 wk after BM 
reconstitution. Depletion of two major RDC subsets 
(CD103+ and CD11bhi) from the lungs was determined 
24 h after DTx treatment. Percentages (mean ± SEM) 
of DC among CD11c+MHC IIhi cells were 13.2 ± 2.5 
versus 0.6 ± 0.08 for CD103+ (P < 0.003) and 42 ± 5.5 
versus 8.2 ± 1.1 for CD11bhi RDC (P < 0.001) for PBS-
treated versus DTx-treated mouse panels, respectively. 
Data in B and C is representative of two independent 
experiments using two mice per experiment. (D) BM 
donor RDC were required for the presentation of re-
sidual vial antigen in the DLN of the previously in-
fected mice. RDC-depleted mice, as described in C, were infused i.v. with CFSE-labeled reporter CD8+ or CD4+ Tg T cells 3 d after DTx (right) or PBS (left) 
treatments, and T cell proliferation in vivo was examined 4 d after transfer. Percentages (mean ± SEM) of divided cells (CFSElow) were 25.2 ± 4.2 versus 5.1 ± 
0.9 for CD8 T cells (P < 0.004) and 65.1 ± 3.5 versus 15.3 ± 2.6 for CD4 T cells (P = 0.0001) for PBS-treated versus DTx-treated mice, respectively. (E) CD8+  
T cells were capable of proliferating in the MLN when antigen was delivered via the i.v. route. Mice treated as in D received i.v. infectious A/PR/8 virus at the 
time of T cell transfer. Data in D and E are representative of three independent experiments using one to two mice per experiment.1168 Persistent antigen depots and local T cell responses | Kim et al.
lyzed the proliferative potential and activation state of the in­
fluenza NP­specific memory T cells enriched in the DLNs. 
When evaluated at 40 d p.i., the cells demonstrated no signif­
icant BrdU uptake (12­h in vivo labeling), displayed back­
ground levels of expression of the proliferation marker Ki­67, 
and expressed elevated levels of the early activation marker 
CD69 (Fig. S7).
Because lymphoid tissues like LNs can undergo substan­
tial morphological changes (e.g., increase in size and number/
distribution of HEV, etc.) in response to inflammatory stim­
uli like virus infection (Soderberg et al., 2005), the difference 
in the distribution of influenza­specific memory T cells be­
tween the DLN and non­DLN could simply be a reflection 
of the anatomical changes associated with the induction and 
development of immune responses in the DLN. If, however, 
in the influenza model, migrant RDCs displaying residual 
antigen obtained from the respiratory tract depot are playing 
a more direct role in controlling the distribution and fre­
quency of memory cells, then depletion of the CD103+ and 
CD11bhi RDC from the respiratory tract might be expected 
to diminish the number of detectable memory cells selec­
tively within the draining MLN. To explore this possibility, 
we transiently depleted these two RDC subsets from the 
lungs of DTR mice 30 d after influenza infection by low­
dose DTx administration and determined the number of en­
dogenous antigen­specific CD8+ and CD4+ memory T cells 
in the draining MLN 4 d later (Fig. 6 B). Transient depletion 
of RDC resulted in a significant (50%) decrease in the 
number of IFN­+CD8+ (Fig. 6 C) and CD4+ (Fig. 6 D)   
T cells in the draining MLN, with a minimal impact on those 
in the pLN. The effect of DTx treatment could be directly 
attributed to the loss of RDC from lungs. In a companion 
analysis, i.n. adoptive transfer of uninfected wild­type DC 
may play a role in the maintenance and trafficking of the 
memory T cell pool generated during infection or vaccina­
tion  (Fazilleau  et  al.,  2007b;  Woodland  and  Kohlmeier, 
2009). To date, much of the information concerning the role 
of residual antigen in the regulation of T cell memory has 
come from adoptive transfer studies using TCR Tg T cells 
(typically naive T cells) to analyze memory T cell formation/
maintenance in conjunction with the duration of antigen 
persistence (Jelley­Gibbs et al., 2005, 2007; Zammit et al., 
2006; Fazilleau et al., 2007a).
To evaluate the impact of residual viral antigen on the 
maintenance of the endogenous memory T cell pool after in­
fection, we first examined the frequency of polyclonal influ­
enza–specific memory CD8+ and CD4+ T cells in the draining 
MLN at days 30 and 70 p.i. by enumerating IFN­–secreting 
cells in response to stimulation by influenza virus–infected 
BMDC. In parallel, we determined the frequency of virus­
specific memory T cells in the nondraining peripheral LNs 
(pLNs), as these secondary lymphoid tissues would be mini­
mally, if at all, colonized by migrant RDC from the infected 
lungs. As observed in Fig. 6 A, elevated numbers of CD4+ 
and CD8+ IFN­–secreting T cells were found in the drain­
ing MLN at both 30 and 70 d p.i. Importantly, the frequency 
(and total number) of these responding cells was significantly 
greater in the draining MLN nodes relative to that of these 
memory cells in the nondraining pLN. These findings support 
the emerging view that after antigen exposure, the mainte­
nance of antigen­specific memory T cells, as well as the dis­
tribution of the memory T cells among various secondary 
lymphoid tissues, may be regulated by the local availability of 
residual antigen within the specific site and adjoining tissues 
(Jelley­Gibbs et al., 2005; Zammit et al., 2006; Fazilleau et al., 
2007a,b; Woodland and Kohlmeier, 2009). We further ana­
Figure 6.  Enrichment of memory T cell numbers  
in the DLN requires the continuous recruitment of 
antigen-bearing migrant RDC. (A) Enrichment of antigen-
specific memory T cells in the LN draining the initial site 
of virus replication. Single cell suspensions prepared 
from lung–draining (MLN) or axillary and inguinal LN 
(pLN) of mice previously infected with A/PR/8 at the 
indicated time points were co-cultured with A/PR/8-
infected BMDC, as APC and IFN--secreting T cells were 
detected by intracellular cytokine staining. Data for each 
day analyzed are representative of four independent 
experiments using one mouse per experiment. (B–D) Lung- 
resident CD11chi DCs are required for maintaining the 
elevated number of antigen-specific polyclonal T cells in 
the lung DLN. (B) Schematic depiction of the time course 
of ablation of RDC from previously infected DTx-treated 
CD11c-DTR mice and reconstitution of the RDC-depleted 
lungs with DC. CD11c-DTR mice (day 30 p.i.) were given 
DTx i.n. The DTx-treated DTR mice then received either  
DC or alveolar macrophages (AM) i.n. 6 h after DTx treat-
ment. Antigen-specific memory T cells were enumerated 
4 d later. (C and D) Absolute numbers of IFN-–secreting polyclonal CD8+ (C) or CD4+ (D) T cells in the DLN upon restimulation with infected BMDC 
in vitro for 5 h as described in A. Data in C and D represent mean ± SEM values from four to seven individual experiments each using one animal 
per experiment.JEM VOL. 207, June 7, 2010 
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draining MLN and analyzed directly ex vivo, and elimination 
of these two RDC subsets from the previously infected respi­
ratory tract abolishes the capacity of the draining MLN to 
support T cell activation/proliferation. In this regard, it is 
noteworthy that resident DCs within secondary lymphoid or­
gans, for example, conventional DCs and pDCs, are thought to 
have relatively short life spans (from 3 to 7 d; Kamath et al., 
2002), and these blood­derived DCs are thus unlikely to re­
tain a pool of antigen within the DLN because of their rapid 
turnover. RDCs display a basal level of migration out of the 
respiratory tract to the draining MLN (without an acute in­
flammatory stimulus; Jakubzick et al., 2008; Kim and Braciale, 
2009). As we demonstrate in this paper, these RDCs contin­
ued to migrate from the lungs to the draining MLN well after 
nominal clearance of infectious virus, probably in response to 
the low level of residual inflammation in the infected lungs at 
late times after infection. This property makes RDCs ideal 
candidates to capture antigen from a reservoir of viral pro­
tein within the previously infected lungs and transport it 
to the DLN.
We  could  detect  mRNA  encoding  the  influenza  NP 
gene product, as well as mRNA for the alternatively spliced 
NS gene product NEP and spliced M gene product M2, in 
the lungs for up to 30 d p.i, which is well after infectious   
virus clearance from lungs (Fig. 1). Moreover, immunofluores­
cent staining of lung tissue revealed that the viral NP could 
likewise be detected in the previously infected lungs for up to 
30 d p.i., largely within CD45 cells located in sites of focal 
inflammation reminiscent of iBALT. The presence of viral 
transcripts and viral protein in the lungs at these later times 
after infection in the absence of detectable viral gene expres­
sion in the draining MLN makes this depot of viral antigen 
the likely ultimate source of the viral antigen presented by 
migrant RDC to T cells in the draining nodes. It is also note­
worthy that viral gene expression persists in the face of a 
vigorous adaptive immune response, which results in the 
elimination of both infectious virus and the vast majority of 
virally infected cells in the respiratory tract. We cannot for­
mally determine whether infectious virions are assembled and 
released from this viral antigen reservoir, as high levels of cir­
culating neutralizing antibodies in these animals preclude de­
tection of infectious virions in the lung tissue at these later 
times p.i. The cell types expressing the influenza viral genes 
and the mechanism by which these cells escape elimination 
by the immune system remain to be determined. However, 
beyond 30 d p.i., although viral RNA and/or protein is not 
demonstrable, viral antigen is present and retained in some 
recognizable form by influenza­specific CD8+ and, more 
notably, by CD4+ T cells because T cell proliferation is de­
monstrable in the draining MLN for >70 d p.i. (Jelley­Gibbs   
et al., 2005; unpublished data). The nature of this reservoir of 
the viral antigen is open to speculation. One potential cellular 
reservoir of the antigen, which is long lived, irradiation resis­
tant, and CD45, is FDC (Mandels et al., 1980). Although 
these cells are normally not found in the lungs of naive mice 
after influenza infection and the formation of iBALT, FDCs 
into infected DTx­treated DTR mice 4 h after toxin treat­
ment restored antigen­specific IFN­–secreting T cell num­
bers in the draining MLN, whereas i.n. transfer of alveolar 
macrophages failed to restore antigen­specific T cell numbers 
(Figs. 6, C and D).
DISCUSSION
In this paper, we have analyzed antigen presentation in influ­
enza­infected mice using the induction of T cell responses in 
vivo to monitor viral antigen persistence after the resolution 
of an acute respiratory virus infection. We have found that 
processed viral antigen may persist for an extended time pe­
riod, i.e., up to day 70 p.i., in the lung­draining MLN, as 
measured by the ability of the transferred antigen­specific 
TCR Tg T cells to proliferate in the MLN. This finding is in 
agreement with previously reported observations (Jelley­
Gibbs et al., 2005, 2007; Zammit et al., 2006; Fazilleau et al., 
2007a), which implicated the secondary lymphoid organs 
(e.g., LNs draining the site of the initial infection) as sites of 
persistent antigen deposition after infection or vaccination. 
However, we have gone on to demonstrate that, in the case 
of respiratory virus infection with influenza, this small persis­
tent reservoir of viral antigen (in the form of influenza viral 
RNA and protein) is localized to the site of infection, i.e., the 
lungs. Viral antigen (influenza NP) colocalized with both 
CD45 and, to a lesser extent, CD45+ lung cells within re­
sidual small inflammatory loci. We were able to reconcile this 
apparent discrepancy, i.e., MLN for the site of T cell activa­
tion and lungs for antigen persistence, by demonstrating that 
RDCs capture the residual viral antigen deposited in the pre­
viously infected lung and then migrate to the MLN where 
they present the in vivo–processed antigen to T cells. Our 
results further suggest that the presentation of residual viral 
antigen by the migrant RDC in the MLN appears to have   
a previously unrecognized role in regulating the memory   
T cell pool in the draining MLN after infectious virus clearance 
and recovery from the infection.
There is accumulating evidence in several models of ex­
perimental respiratory tract viral infection, i.e., VSV, RSV, or 
influenza virus, that viral antigen in a form of processed peptide 
persists in the LN, draining the site of initial pathogen entry 
(Schwarze et al., 2004; Jelley­Gibbs et al., 2005; Turner et al., 
2007). It has been speculated that the viral antigen in the 
DLN may be retained in cells capable of presenting the anti­
gen to antigen­specific memory T cells. In spite of efforts to 
identify the cell type that supports the proliferation of T cells 
in LNs draining sites of infection, the nature of antigen­present­
ing cells in the DLN has not been elucidated. Our analysis 
suggests that, in the case of acute viral infection of the respiratory 
tract, it is these two subsets of CD11chiMHC Class IIhi RDCs, 
i.e., CD103+ and CD11bhi RDCs (Sung et al., 2006; Kim and 
Braciale, 2009), which carry out this APC activity in the 
DLN after their migration from the previously infected lungs. 
Two  lines  of  evidence  support  this  view:  CD103+  and 
CD11bhi RDC are the only DC subsets capable of supporting 
significant T cell proliferation when isolated from the lung­1170 Persistent antigen depots and local T cell responses | Kim et al.
peptides to the antigen­specific T cells. As a consequence, this 
ongoing residual antigen recognition by memory T cells may 
be an important event resulting in the selective enrichment of 
virus­specific memory T cells in the DLN after the clearance 
of infectious agent. This enriched population of antigen­specific 
T cells maintained in the antigen DLN would likely provide 
a more rapid and robust recall T cell response to a reinfection. 
These findings suggest that immunization strategies using long­
lasting vaccines deposited at body surfaces where the target 
pathogen enters the body (e.g., the respiratory tract or GI tract) 
may be the most effective way to sustain and recall a memory 
adaptive immune response.
MATERIALS AND METHODS
Mice and infection. Female BALB/c mice (H­2d) were purchased from 
Taconic. Tg mice expressing nonhuman primate DTR under the control of 
the mouse CD11c­promoter (C.FVB­Tg Itgax-DTR/EGFP 57Lan/J, H­2d) and 
Thy­1.1 Clone 4 (Cl­4) TCR Tg mice (H­2d) were obtained from The 
Jackson Laboratory. Thy­1.2 Cl­4 TCR Tg mice (H­2d) were a gift from 
R.W. Dutton (Trudeau Institute, Saranac Lake, NY). TS1 TCR Tg mice 
(I­A/Ed) were provided by A. Caton (Wistar Institute, Philadelphia, PA), which 
are bred and housed in a pathogen­free environment and used at 9–13 wk   
of age for all experiments. To delete CD11c+ cells, DTR Tg mice were   
injected i.n. with 30 ng DTx/60 µl PBS (Sigma­Aldrich). All animal ex­
periments were performed in accordance with protocols approved by the 
University of Virginia Animal Care and Use Committee.
Type A influenza viruses A/PR/8/34 (H1N1) or X­31 (H3N2) were 
grown in day 10 chicken embryo allantoic cavities as described previously 
(Lawrence and Braciale, 2004). Mice were infected either i.n. in 50 µl with 350 
egg infectious doses (EID) or i.v. in 500 µl via tail vein with 1.7 × 107 EID.
Preparation of tissue leukocytes. Preparation of lung single cell suspen­
sions after enzymatic digestion was described in detail elsewhere (Stevens et al., 
2007). For DC isolation from LN, tissues were minced and enzymatically 
digested with Type II collagenase (37°C for 20 min), followed by passing 
through Cell Strainer (BD). RBCs in the cell suspensions were lysed using 
ammonium chloride. Cells were washed and resuspended in FACS buffer 
containing PBS, 2% FBS, 10 mM EDTA, and 0.01% NaN3 for Ab staining 
or MACS buffer containing PBS, 2% FBS, and 10 mM EDTA for sorting. 
Viable nucleated cells in the suspensions were counted using a hemacytome­
ter after exclusion of dead cells using Trypan blue dye.
Antibodies. The mAbs were purchased from BD or eBioscience (unless 
stated), and clones were previously described in detail (Kim and Braciale, 
2009). Anti–mouse CD16/32 used for Fc receptor blocking was isolated and 
purified in our laboratory. For biotinylated mAbs, samples were incubated 
with streptavidin (SA)­RPE, SA­APC or SA­APC­Cy7.
Flow cytometry analysis and intracellular staining. Cell suspensions 
were blocked with 2.4G2 and then incubated with specific mAbs or isotype 
controls for 25 min on ice. Surface marker staining and intracellular cytokine 
staining were described previously (Stevens et al., 2007; Kim and Braciale, 
2009). For identification of antigen­specific polyclonal CD8 or CD4 T cells 
in the tissues, single cell suspensions were co­cultured with infectious virus­
pulsed BMDC for 5 h to stimulate antigen­specific T cells as described previ­
ously (Sun et al., 2009). Flow cytometry was performed on either FACSCalibur 
or FACSCanto flow cytometers (BD), and data were analyzed using FlowJo 
(Tree Star, Inc.).
T cell and DC isolation and in vitro co-culture. The isolation of CD8+ 
T cell, CD4+ T cell, or DC subsets and their co­culture were described else­
where in detail (Kim and Braciale, 2009).
can localize in follicles formed within the iBALT (Moyron­
Quiroz et al., 2004). Our findings using in vivo depletion of 
FDC by LTR blockade (Fig. S5) support the idea that 
FDC present in the previously infected lungs may, like 
CD11chi  MHCIIhi RDC, play an important role in controlling 
the retention of memory T cells within the DLNs. Whether 
these cells serve as the ultimate, or even most effective, reservoir 
for residual viral antigen remains to be determined. Neverthe­
less, although not formally explored in this paper, we would 
speculate that iBALT­like structures within the previously in­
fected lungs may be important sites of influenza viral anti­
gen deposition where CD45 cells, such as FDC, may interact 
with CD45+ RDC to regulate memory T cell populations 
within the DLNs.
The preferential localization of memory CD8+ and CD4+ 
T cells to the LNs draining the site of infection, observed by 
us in this paper and by others (Hogan et al., 2001; Marshall 
et al., 2001; Jelley­Gibbs et al., 2005; Zammit et al., 2006), is 
a potentially useful adaptation for the adaptive immune sys­
tem to deal with repeat infections by a given pathogen. This 
strategy allows for rapid mobilization of the memory response 
through a concentration of central memory cells in the LNs 
draining the likely site of subsequent infection. Using the 
DTR mouse model, we demonstrate that elimination of the 
critical CD103+ and CD11bhi RDC from the influenza­
infected respiratory tract before the RDC migration to the 
DLN substantially decreases the numbers of virus­specific en­
dogenous (wild type) memory CD8+ and CD4+ T cells pres­
ent in the DLN within days of RDC elimination. Furthermore, 
adoptive transfer of DC (but not alveolar macrophages) into 
the respiratory tract of DTx­treated DTR mice restores mem­
ory T cell numbers within the DLN. Although strong in­
flammatory stimuli can alter the architecture of LNs draining 
the site of the inflammatory stimulus, resulting in preferential 
accumulation of T cells within the DLN (Soderberg et al., 
2005), our findings, in particular the rapid loss of memory T 
cells from the DLN after RDC depletion from the lungs, are 
more consistent with an active role for these migrant viral 
antigen­bearing RDCs in retaining memory cell numbers 
within the DLN. The nature of the interaction between the 
memory T cells and the RDC leading to T cell retention in 
the DLN remains to be elucidated. Our analysis (Fig. S7) 
does, however, indicate that the accumulation of the mem­
ory T cells in the draining MLN appears not to be a result of 
ongoing proliferation of the memory T cells. Rather, the el­
evated expression of CD69 would favor a model where the 
interaction of memory T cells with the migrant RDC results 
in the CD69­dependent (Shiow et al., 2006) selective reten­
tion of the memory T cells within the draining nodes.
In summary, our study provides insight into the process by 
which viral antigen persists after acute respiratory virus infec­
tion and the mechanism through which the prolonged in vivo 
antigen presentation occurs. Our results suggest that RDCs 
found at the site of primary infection (i.e., the lungs) play a 
pivotal role in sampling the residual viral antigen and, upon 
migration to the DLN, directly present the in vivo–processed JEM VOL. 207, June 7, 2010 
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of RDC present in the previously infected lungs for retention of residual 
viral antigens and stimulation of T cells ex vivo. Fig. S5 demonstrates that 
the blockade of signaling mediated by LTRs in vivo diminished antigen 
presentation in the DLN of the previously influenza­infected lungs. Fig. S6 
demonstrates that the blockade of LTR­mediated signaling at earlier time 
points had no or minimal impact on the recruitment and subsequent pro­
liferation of T cells in the DLN of the previously influenza­infected lungs. 
Fig. S7 demonstrates that enrichment of memory T cell numbers in the 
DLN is mediated by CD69­dependent retention rather than local de novo 
proliferation. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20092017/DC1.
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